Expression and Activity of Matrix Metalloproteinases in Leukemia. Issue 2 (March 2019)

• Record Type: Journal Article
• Authors: Amin Asnafi, Ali; Bagheri, Marziye; Zibara, Kazem; Maleki Behzad, Masumeh; Shahrabi, Saeid
• Is Part Of: Journal of pediatric hematology/oncology. Volume 41:Issue 2(2019)
• Publication Date: 2019-03
• Subjects: matrix metalloproteinases -- leukemia -- hematopoietic stem cells -- angiogenesis -- apoptosis -- prognosis; Pediatric hematology -- Periodicals; Tumors in children -- Periodicals; 618.9215
• DOI: 10.1097/MPH.0000000000001386
• Languages: English
• ISSNs: 1077-4114

Abstract

Abstract : Matrix metalloproteinases (MMPs) are responsible for the degradation of extracellular matrix components and hence play a crucial role in physiological and pathologic processes. The imbalance between the expression of MMPs and their inhibitors can be effective in leukemic cell processes such as migration, angiogenesis, survival, and apoptosis, playing a key role in the progression and prognosis of leukemia. In this review, we discuss the potential involvement of MMPs and their inhibitors in the pathogenesis and progression of leukemia by examining their role in the prognosis of leukemia. Inducing leukemic cell growth, migration, invasiveness, and angiogenesis are the main roles of MMPs in leukemia progression mediated by their degradative activity. Given the important role of MMPs in leukemia progression, further clinical trials are needed to confirm the link between MMPs' expressions and leukemia prognosis. It is hoped to use MMPs as therapeutic targets to improve patients' health by recognizing the prognostic value of MMPs in leukemia and their effect on the progression of these malignancies and their response to treatment. Abstract : Supplemental Digital Content is available in the text.